Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, K. P.
Right arrow Articles by Britt, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, K. P.
Right arrow Articles by Britt, J. E.

Chest, Vol 93, 993-997, Copyright © 1988 by American College of Chest Physicians


ARTICLES

Percutaneous needle aspiration biopsy of chest lesions. New instrument and new technique

KP Wang, SJ Kelly and JE Britt
Department of Respiratory Medicine, Johns Hopkins Hospital, Baltimore 21205.

From March 1986 to April 1987, 70 percutaneous needle aspiration (PCNA) procedures were performed in 66 consecutive patients. Seven immunocompromised patients had the procedure performed to obtain culture material from the lung, and 59 patients with chest lesions were analyzed. This includes 49 patients with either a lung nodule or mass. In the remaining ten patients, there were three chest wall or pleural lesions, two aortic pulmonary window lesions, two right hilar lesions, and three anterior mediastinal lesions. Forty of these 59 patients were ultimately proven to have a malignancy. The diagnostic yield for malignant disease by cytology and histology of PCNA was 97.5 percent (39 of 40). Twelve patients had a final diagnosis of benign disease. The diagnostic yield in benign diseases by PCNA was 91.6 percent (11 of 12). The remaining seven patients do not yet have a final diagnosis, though the clinical course favors benign disease in six of these patients. We attribute the major reason for this high specific diagnostic yield in both malignant and benign diseases to the ability of obtaining histologic specimens for interpretation.


This article has been cited by other articles:


Home page
ChestHome page
C. Hagl, W. Harringer, B. Gohrbandt, and A. Haverich
Site of Pleural Drain Insertion and Early Postoperative Pulmonary Function Following Coronary Artery Bypass Grafting With Internal Mammary Artery
Chest, March 1, 1999; 115(3): 757 - 761.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
V. J Lowe and K. S Naunheim
Current role of positron emission tomography in thoracic oncology
Thorax, August 1, 1998; 53(8): 703 - 712.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.